With a mission to revolutionize the stenting industry, InspireMD aims to address key clinical issues such as embolic showers, restenosis, and late stent thrombosis. Their cutting-edge technology, applied to both bare metal and drug eluting stents, targets interventional cardiology and other vascular procedures. The company's flagship products, CGuard carotid Embolic Prevention System (CGuard EPS) and MGuard Prime Embolic Protection System (MGuard Prime EPS), have gained traction globally. By combining MicroNet and a self-expandable nitinol stent in a single device, CGuard EPS offers a superior solution for carotid artery applications. Operating in multiple countries, including Germany, Italy, Belarus, and Brazil, InspireMD is committed to establishing its stent system technology as the industry standard.